Teriflunomide (Aubagio, Genzyme/Sanofi) is coming into the MS market . It is an oral drug, nice. Efficacy: “30% lower than the rate for those taking a placebo,” said Russell Katz, MD,” What does that mean? Maybe not as clear as just a percent reduction in releases, think compounding. Sagepub …Read the Rest
OUR MISSIONHealth research is moving at such a fast pace that one needs an "ear to the ground" to follow and sift through the immense amount of data coming our way. We include classical and alternative medicine,nutrition, pollution and environmental issues. We also have a bit of a contrarian approach, so expect us to question medical and health fads. MediNewsDigest particularly follow autoimmune conditions, diabetes and related issues as well as heart conditions.
DisclaimerThe MediNewsDigest and it's posts are to bring your attention to topics that could benefit you and should discussed with your Doctor or other medical professional. The staff is not medically trained and posts are of a journalistic nature and not in lieu of medical advice. MediNewsDigest will not be held liable for any damages incurred using the Blogs, data or links provided